Inhibiting degradation of 2-arachidonoylglycerol as a therapeutic strategy for neurodegenerative diseases

Neuroscience

• 2-Arachidonoylglycerol 100%
• Neurodegenerative Disorder 100%
• Acylglycerol Lipase 60%
• Brain 50%
• Neuroprotective Agent 20%
• Traumatic Brain Injury 20%
• Neurotransmission 20%
• Agonist 10%
• Synapse 10%
• Cannabis 10%
• Enzymes 10%
• G Protein 10%
• Multiple Sclerosis 10%
• Tetrahydrocannabinol 10%
• Parkinson's Disease 10%
• Synaptic Plasticity 10%
• Prostaglandin 10%
• Arachidonic Acid 10%
• Lipid Signaling 10%
• Leukotriene 10%
• Lipase Inhibitors 10%
• Neuron 10%
• Cognitive Function 10%
• Astrocyte 10%

Biochemistry, Genetics and Molecular Biology

• Degradation 100%
• 2-Arachidonoylglycerol 100%
• Monoacylglycerol Lipase 60%
• Electric Potential 20%
• Hydrolase 20%
• Endocannabinoids 20%
• Agonist 10%
• Mediator 10%
• Homeostasis 10%
• G Protein 10%
• Precursor 10%
• Plasticity 10%
• Arachidonic Acid 10%
• Metabolic Pathway 10%
• Astrocyte 10%
• Lysozyme 10%
• Cannabinoid Receptor 10%
• Synapse 10%
• Cognition 10%
• Glutamatergic 10%
• Tetrahydrocannabinol 10%
• Leukotriene 10%
• Lipid Signaling 10%
• Light 10%
• Comprehension 10%
• Animal Models 10%
• Genetics 10%